Delivery Order 75N93018D00008-75N93019F00131
Award Date 3/22/19
Potential Completion Date 3/21/20
Potential Value $543K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albany, NY 12203, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for Task C03 under the Nonclinical Services for Development of Interventional Agents contract, a delivery order awarded to Curia Global Inc., doing business as Amri. Amri is a leading contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to federal agencies, particularly the National Institutes of Health (NIH) and its institutes. The award has a total ceiling value of $860,162.70...
- This federal contract task order was awarded by the U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $1,376,049.53 cost-plus-fixed-fee task order, awarded on August 15, 2018, supports the Medicinal Chemistry Support Program for Therapeutic Development, providing chemistry, manufacturing, and controls...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $610,340.86, is a delivery order under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract directs Curia to prepare 400 grams of non-GMP (good manufacturing practice)...
- This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and...
- This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $2,873,042.91 contract is for the Medicinal Chemistry Support Program for Therapeutic Development, under which Curia will provide a range of chemistry, manufacturing, and controls development...
- This federal contract award, valued at $2,592,564.37, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc. (doing business as Amri), a leading global contract development and manufacturing organization (CDMO). The award is for a Delivery Order under the Biomedical Prototype Network - Medicinal Chemistry Support Program for Therapeutic Development (BPN-MCSP-HIT) to support chemistry-related services, including hit-to-lead chemistry, for the Martin...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $443,000 delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract to Curia Global Inc., doing business as Amri. This firm fixed price order is for non-clinical services and will be performed in Spain from September 14, 2022 through December...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,297,587.74 cost-plus-fixed-fee delivery order to Curia Global Inc. (doing business as Amri) for the Medicinal Chemistry Support Program for Therapeutic Development. This program supports medicinal chemistry and other drug discovery and development services to advance treatments for conditions such as Alzheimer's disease, Parkinson's disease, pain, substance abuse, and...
- This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, for the Medicinal Chemistry Support Program for Therapeutic Development. The contract, with a potential value of $4,042,434.33, provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry; absorption/distribution/metabolism/excretion testing; process...
- This is a federal contract award to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The award, with a ceiling value of $2,755,155.31, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, under the Drug Manufacturing and Formulation Program (DMFP) indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is a delivery order and has a pricing type of cost plus...